Industries > Pharma > RNA Analysis/Transcriptomics Market Report 2020-2030

RNA Analysis/Transcriptomics Market Report 2020-2030

Forecasts by Type (Microarrays, Polymerase Chain Reaction (PCR), Sequencing Technologies, RNAI Gene Silencing), by Application (Clinical Diagnosis, Drug Discovery, Toxicogenomic), by End-user (Academic Research & Government Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Centers), by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) PLUS Analysis of Leading Medical Device Contract Manufacturing Companies AND COVID-19 Recovery Scenarios

PUBLISHED: 30 October 2020
PAGES: 466
PRODUCT CODE: PHA0973
SUBMARKET: Biotechnology

Clear
WOOCS 2.2.1
SKU: PHA0973 Categories: , Tag:

Demand for RNA Analysis/Transcriptomics Technologies
Increasing demand for personalised medicines by end users and manufacturers followed by technological advancement in the field of RNA analysis will open new avenues for the market in coming years. Hectic lifestyle followed by changing dietary habits in developed as well developing economies have increased prevalence of chronic diseases such as cancer and diabetes. All these factors will increase demand for RNA analysis/Transcriptomics technologies for drug development and discovery. However, the shortage of trained specialists coupled with challenges of handling sequencing data will be the key market restraining factors.

What are the Market Driving Factors?
• Increasing Technological Advancements in The Field of Omics Research
• Increasing Preference for Personalized Medicine

Key Challenges and Threats for RNA Analysis/Transcriptomics Market
• Shortage of Skilled Professionals
• Dearth of Effective Bioinformatics tools

What are the Market Opportunities?
• Transcriptomic Technologies in the Field of Drug and Biomarker Discovery
• Increasing R&D Spending of Biopharmaceutical Companies
• Investment, and Future Aspects of RNA Therapeutics

Leading companies and the potential for market growth
• The global RNA analysis/transcriptomics market is consolidated in nature as top 7 companies operating in this industry accounted for >40% of the overall market share.
• Key companies operating in this industry are Affymetrix Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., GE Healthcare, Illumina, Inc., Qiagen N.V., F. Hoffmann-La Roche Ltd., Sigma-Aldrich Corporation, Thermo Fisher Scientific, Inc., and Fluidigm Corporation.
• Prominent players operating in this industry are adopting mergers & acquisitions, new product development, technological advancement, and partnership strategies in order to gain competitive edge in this industry. For instance, in April 2020, Bio-Rad Laboratories acquired Celsee, a company engaged in offering instruments and consumables for single-cell analysis.

This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.

To access the data contained in this document please email contactus@visiongain.com

Global RNA Analysis/Transcriptomics Market by Type
• Microarrays
• Polymerase Chain Reaction (PCR)
• Sequencing Technologies
• RNAI Gene Silencing

Global RNA Analysis/Transcriptomics Market by Application
• Clinical Diagnosis
• Drug Discovery
• Toxicogenomic

Global RNA Analysis/Transcriptomics Market by End User
• Academic Research & Government Institutes
• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic Centers

CTA

Global RNA Analysis/Transcriptomics Market by Region

• North America
• U.S.
• Canada

• Europe
• Germany
• UK
• France
• Rest of Europe

• Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

• Latin America
• Brazil
• Mexico
• Argentina
• Rest of Latin America

• Middle East & Africa
• GCC
• South Africa
• Rest of Middle East & Africa

Need industry data? Please contact us today.

How the Global RNA Analysis/Transcriptomics Market report helps you?
• In addition to revenue forecasting to 2030, our new study provides you with recent market development and future aspects such as Next Generation Sequencing Technology, Biopharmaceutical R&D Expenditure, Technological Advancement in Omics Research
• Qualitative analyses such as market drivers, opportunities, restraints, challenges, SWOT analysis, Porter’s Five Forces model, company market share analysis, investment and future aspects of RNA therapeutics and commercial developments.
• Revenue forecasts to 2030 for Global RNA Analysis/Transcriptomics Market, with forecasts for Type, Application, and End User, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Additionally, the RNA Analysis/Transcriptomics Market study analyses vendor landscape using company profiles, revenues, business segment, and company market share analysis.

To access the data contained in this document please email contactus@visiongain.com

Buy our report today RNA Analysis/Transcriptomics Market Report 2020-2030: Forecasts by Type (Microarrays, Polymerase Chain Reaction (PCR), Sequencing Technologies, RNAI Gene Silencing), by Application (Clinical Diagnosis, Drug Discovery, Toxicogenomic), by End-user (Academic Research & Government Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Centers), by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) PLUS Analysis of Leading Medical Device Contract Manufacturing Companies AND COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for RNA Analysis/Transcriptomics Market Report 2020-2030


Download sample pages

Complete the form below to download your free sample pages for RNA Analysis/Transcriptomics Market Report 2020-2030


Latest Pharma news

Visiongain Publishes Cancer Diagnostics Market Report 2021-2031

Major investments have been made by companies in the cancer diagnostics industry in the past few years to develop novel tests to capitalize on the opportunities in the untapped market.

19 April 2021

READ

Visiongain Publishes Food for Special Medical Purpose (FSMP) Market Report 2020-2030

The food for special medical purpose (FSMP) market growth can be attributed to the growing prevalence of metabolic diseases, growing consumer unhealthy lifestyle, and surge in demand from emerging economies such as Asia Pacific, Middle East & Africa, Latin America, and others.

12 April 2021

READ

Visiongain Publishes Cell-Based Assays Market Report to 2030

Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.

09 April 2021

READ

Visiongain Publishes Cancer Biologics Therapies Market Report 2021-2031

The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

06 April 2021

READ

Categories